In an attempt to study potential neural markers as adjuncts to alpha fetoprotein in the pre-natal detection of neural tube defects (NTD), we have previously studied! the dimeric glycolytic enzyme Neurone Specific Enolase (NSE) in amniotic fluid samples from pregnancies complicated by NTD and from those of normal outcome. Our study identified that in all cases of anencephaly, the level of NSE in amniotic fluid was significantly elevated above the levels found in normal pregnancies, but in cases of Open and Closed Spina Bifida the NSE levels were not elevated. In a similar smaller study Sorensen et al. 2 have also found raised levels of NSE in the maternal serum of 50% (8 of 15 cases) of pregnancies affected by NTD and this elevation was also found in amniotic fluids, however the increased level of NSE in maternal serum was not always associated with a corresponding increase in amniotic fluid NSE and vice versa. Unfortunately, Sorensen et al. did not identify the specific NTD lesions in cases in their study.
Following our earlier study! we have attempted to confirm the suggestion/ that maternal serum NSE levels may be raised in some cases ofNTD affected pregnancies. We have used the Pharmacia NSE double antibody radioimmu- noassay method as described in our previous study (within assay coefficient of variation at 12·5 ",gIL of 3,3%). We examined the levels of NSE in the maternal serum of NTD affected cases and compared them with those from gestationally matched pregnancies with a normal outcome. All samples had been stored in aliquots at -20"C for a minimum of 3 months and a maximum of 4 years. The results of the study are shown in Table 1 . The reference range quoted for serum NSE by the manufacturer is up to 12·5 f.lglL and no normal or NTD outcome serum samples showed levels above the upper limit of the reference range. A paired r-test using all the NTD cases indicated a t of 0·2005 with a probability of 0·99999. Clearly, there is no significant difference between the NSE levels in the maternal serum of the normal and affected group of pregnancies. We, therefore, cannot confirm the observations of Sorensen et al. 2 in . that in our study no cases of elevated NSE was Serum neurone specific enolase 669 found in the maternal serum from pregnancies affected by NTD. The use of maternal serum NSE as a potential marker of anencephaly or NTD in general is therefore not possible.
